
    
      The present study was a randomized, blinded, controlled clinical trial, which used a
      split-mouth design. Prior to commencement, the study design was approved by the Ethics
      Committee of Bahiana School of Medicine and Public Health (12/2008). All patients were
      informed individually about the nature of the proposed treatment, and informed consent forms
      were signed.
    
  